Research Solutions (NASDAQ:RSSS - Get Free Report) is projected to post its Q3 2025 quarterly earnings results after the market closes on Thursday, May 8th. Analysts expect Research Solutions to post earnings of $0.03 per share and revenue of $13.02 million for the quarter.
Research Solutions (NASDAQ:RSSS - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.09). Research Solutions had a negative return on equity of 6.59% and a negative net margin of 8.41%. The firm had revenue of $11.91 million during the quarter, compared to the consensus estimate of $11.86 million. On average, analysts expect Research Solutions to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Research Solutions Trading Up 3.2 %
RSSS stock traded up $0.09 during trading hours on Friday, hitting $2.87. 17,627 shares of the stock traded hands, compared to its average volume of 89,726. The stock has a 50-day simple moving average of $2.72 and a 200 day simple moving average of $3.22. The company has a market cap of $93.70 million, a P/E ratio of -19.13, a P/E/G ratio of 4.33 and a beta of 0.61. Research Solutions has a one year low of $2.32 and a one year high of $4.24.
About Research Solutions
(
Get Free Report)
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.
Featured Articles
Before you consider Research Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.
While Research Solutions currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
